How is ovarian hyperstimulation syndrome (OHSS) monitored and treated during IVF, and what steps are taken to minimize the risk of this condition occurring?
Gaurav ChauhanContributor
How is ovarian hyperstimulation syndrome (OHSS) prevented and treated?
Share
OHSS during IVF is monitored via ultrasound and hormone levels. Treatment includes hydration and medication. Risk is minimized by adjusting hormone dosages and using a GnRH antagonist.
Ovarian Hyperstimulation Syndrome (OHSS) is a potential complication of in vitro fertilization (IVF) treatment, particularly in women who are undergoing ovarian stimulation. Monitoring and treating OHSS during IVF involve several steps to ensure early detection and appropriate management. Here is a detailed overview:
### Monitoring OHSS during IVF:
1. Ultrasound Monitoring: Regular ultrasound scans are conducted during the ovarian stimulation phase to monitor the growth and number of follicles in the ovaries.
2. Hormone Levels: Blood tests are done to monitor hormone levels, particularly estradiol, which can increase dramatically in cases of OHSS.
3. Symptom Monitoring: Patients are advised to report any symptoms of OHSS, such as abdominal pain, bloating, nausea, vomiting, and reduced urination.
### Treatment of OHSS during IVF:
1. Fluid Management: Mild cases of OHSS may require increased fluid intake, while severe cases may need hospitalization for intravenous fluid therapy to restore electrolyte balance.
2. Pain Management: Over-the-counter pain medications or prescription pain relief may be recommended to manage discomfort.
3. Monitoring: Close monitoring of symptoms, hormone levels, and ultrasound findings is crucial to track the progression or resolution of OHSS.
### Minimizing Risk of OHSS:
1. Individualized Stimulation Protocol: Tailoring ovarian stimulation medications based on the patient’s ovarian reserve and response to previous cycles can help reduce